Are polymorphisms of the SDF1 and CCR2b genes related to the course of hepatitis C or HIV/HCV co-infection?;Beeinflussen polymorphismen des SDF1 - und CCR2b- gens den verlauf der hepatitis C und der HIV/HCV-koinfektion?

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 36, 2002, Pages 1807-1812

  Woitas, Rainer P ^a   Ahlenstiel, G ^a   Iwan, A ^a   Rockstroh, J K ^a   Brackmann, H H ^b   Kupfer, B ^b   Matz, B ^b   Offergeld, R ^b   Sauerbruch, T ^a   Spengler, U ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; STROMAL CELL DERIVED FACTOR 1; VIRUS RNA;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; VIRUS LOAD;

ADOLESCENT; ADULT; CD4-CD8 RATIO; CHEMOKINES, CXC; FEMALE; GENE FREQUENCY; HEPATITIS C, CHRONIC; HETEROZYGOTE; HIV INFECTIONS; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CHEMOKINE; VIRAL LOAD;

EID: 0037032007     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33867     Document Type: Article

References (21)

1. Brambilla A, Villa C, Rizzardi G et al. Shorter survival of SDF1-3′A/3′A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection. J Infect Dis 2000; 182:311-315
2. Dragic T, Litwin V, Allaway GP et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC- CKR-5. Nature 1996; 381: 667-673
3. Emery AEH. Introduction in statistical methods. Methodology in medical genetics, London, New York: Churchill Livingstone. 1986; Second Edition: 3-11
4. Hendel H, Henon N, Lebuanec H et al. Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 381-386
5. Huang Y, Paxton WA, Wolinsky SM et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996; 2: 1240-1243
6. Kostrikis LG, Huang Y, Moore JP et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Med 1998; 4: 350-353
7. Lechmann M, Woitas RP, Langhans B et al. Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J Hepatol 1999; 31: 971-978
8. Mackay CR. Chemokines: immunology's high impact factors. Nature Immunol 2001; 2: 95-101
9. agierowska M, Theodorou I, Debre P et al. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood 1999; 93: 936-941
10. Meyer L, Magierowska M, Hubert JB et al. CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients. SEROCO Cohort. Amsterdam Cohort Studies on AIDS. AIDS 1999; 13: 624-626
11. Michael NL, Louie LG, Rohrbaugh AL et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nature Med 1997; 3: 1160-1162
12. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nature Immunol 2001; 2: 123-128
13. Mummidi S, Ahuja SS, Gonzalez E et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nature Med 1998; 4: 786-793
14. Nanki T, Lipsky PE. Stromal-derived factor-1 is a costimulator for CD4+ T cell activation. J Immunol 2000; 164: 5010-5014
15. Samson M, Libert F, Doranz BJ et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-725
16. Sei S, Boler AM, Nguyen GT et al. Protective effect of CCR5D32 heterozygositiy is restricted by SDF-1 genotype in children with HIV-1 infection. AIDS 2001; 15: 1343-1352
17. Smith MW, Dean M, Carrington M et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997; 277: 959-965
18. van Rij RP, Broersen S, Goudsmit J, Coutinho RA, Schuitemaker H. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-infection. AIDS 1998; 12: F85-90
19. Winkler C, Modi W, Smith MW et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998; 279: 389-393
20. Woitas RP, Ahlenstiel G, Iwan A et al. The frequency of the HIV-protective CC chemokine receptor 5-D32/D32 genotype is increased in hepatitis C antibody positive patients. Gastroenterology 2002; 122: 1721-1728
21. Woitas RP, Rockstroh JK, Beier I et al. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients. AIDS 1999; 13: 1313-1322